Supplementary
GGTTCTTACTTCAGGGCCATCA GATTAGACCCGTTACCATCGAGAT GAPDH (genomic DNA) ACCATGCTTCACTGACATTCTGA GGTCTGCCTCCCTGCTAACC Figure S1 . ChREBP exists as 2 major isoforms. ChREBPα is the "classical" fulllength, glucose-regulated form. ChREBPβ is an alternatively spliced isoform that begins translating at an alternative ATG and therefore lacks the low glucose inhibitory domain (LID, also containing nuclear export signals, NES), and is unrestrained by low glucose, constitutively nuclear and more potent than its longer counterpart. ChREBPβ is induced by a carbohydrate response element (ChoRE) located near the start site of an alternative promoter for ChREBPβ (exon 1b). Thus the induction of the beta isoform leads to an autoregulated feed-forward loop, with the newly synthesized ChREBPβ binding to the carbohydrate response element on its own promoter (and other ChREBP target genes), leading to still more production of ChREBPβ. UTR, untranslated region. bHLH-ZIP, basic, helix loop helix, zipper domain.
Supplementary Figure S2 . Overexpression ChREBPα does not induce ER stress or apoptosis, and only modestly increases ChREBPβ without increasing other ChREBP target genes. A. INS1 cells were transduced with control adenovirus (LacZ), or adenovirus expressing ChREBPα, and were cultured in 2 or 20 mM glucose for 6 h. Total RNA was isolated and processed for RT-PCR using primers specific for the indicated genes. Results are fold change after normalizing to β-actin mRNA using the ΔΔCT method. B. INS1 cells were transduced with control adenovirus (LacZ), or adenovirus expressing ChREBPα or Cherry-tagged ChREBPβ and cultured for 48 h in 2 mM or 20 mM glucose. Inset shows immunoblot shows similar expression and loading using antibodies against C-terminus of ChREBP and β-actin. Cells were fixed and stained with Annexin V APC and the percent Annexin positive cells were determined by flow cytometric analysis. C. Immunoblot using antibodies against cleaved caspase 3 and β-actin as a loading control. D. ATP/ADP ratios were determined. E. Glucose stimulated insulin secretion. Human islets were treated with Ad.ChREBPα or Ad.LacZ. Insulin secretion and content were measured after 30 min in 5.5 or 20 mM glucose and the results were expressed relative to the Ad.LacZtreated islets that were stimulated with 5.5 mM glucose. Data shown are the mean ± SE, n=4 *p < 0.05. Supplementary Figure S6 . Effects of ChREBPα on mitochondrial biogenic genes. INS1 cells were transduced with Ad.ChREBPα or Ad. LacZ and treated with 2 or 20 mM glucose. Total RNA was isolated and processed for RT-PCR (A-C and E-I) using primers for the indicated genes, or lysates were processed for immunoblotting (D) using antibodies against PGC1α, PGC1β, or β-actin. The RT-PCR results are fold change after normalizing to β-actin mRNA using the ΔΔCT method. Mean ± SE, n=3-5, *p < 0.05, **p < 0.01.
Supplementary Figure S7 . Overexpression of ChREBPα, Nrf2 or Keap1 does not increase apoptosis in human beta cells. Human islets were dispersed and transduced with the indicated adenoviruses for 48 hours and then subjected to TUNEL assay. Results shown are the mean +/-SE, n=3.
Supplementary Figure S8 . Glucose and Nrf2 treatment decreases ROS production. INS1 cells were transduced with the indicated adenoviruses for 30 h, followed by culture in either 2 or 20 mM glucose for 18 h. ROS generation was measured and normalized to cell number. Data are mean +/-SE, n=3; *, p < 0.05 (vs. 2 mM glucose, LacZ control).
